by Camila Londono | Oct 25, 2016
The fifth Till & McCulloch Meetings started off with a bang, with an incredibly exciting and provocative talk by Dr. Sara-Jane Dunn that highlighted the predictive power of Boolean network models. Dr. Dunn, who works at Microsoft Research, introduced the idea of...
by Stacey Johnson | Jan 22, 2016
Does it seem like regenerative medicine is having its moment in the sun? Last week, the news that GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies, with $20 million...
by Stacey Johnson | Aug 21, 2015
. Last night, I took my daughters to a One Direction concert. Regardless of what you might now think of me (us), they still have several (million) fans around the world. The 40,000 screaming girls in attendance at the Rogers Centre showed the Brit boys lots of love....
by Mark Curtis | Apr 7, 2015
. Welcome to your Update from the Clinic for the month of March. Investors weren’t so keen on Neuralstem’s topline results in amyotropic lateral sclerosis (ALS). NeoStem’s follow-up data from its PreSERVE study in acute myocardial infarction (AMI) was somewhat...
by Peter Raaymakers | Feb 27, 2015
Hematopoiesis is a long word, but in essence it describes a pretty straight-forward concept: The formation of our blood system, including all of its components. It’s a multi-step process beginning with stem cells and ending with mature, specialized ones like red...
Comments